Browse Data and Analysis

Kazakhstan's draft biotech law could remain stalled until the country's WTO accession. Meanwhile, new Customs Union regulations address labeling and import of biotech products.

The EU is plagued by a highly regulated system that has hindered its ability to react to the supply shortfalls seen over the last few years.